Novel <i>BCR-ABL1</i> tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Sara Malik, Shahzeb Hassan, Ahmet Emre Eşkazan
Abstract
KEYWORDS: Asciminibchronic myeloid leukemiaflumatinibHQP1351K0706novel therapiesolverembatinibPF-114tyrosine kinase inhibitorvodobatinib
Topics & Concepts
MedicineMyeloid leukemiaTyrosine kinaseCancer researchTyrosine-kinase inhibitorInternal medicineCancerReceptorChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia Research